Blog

Cover image for a Carelane article on how CROs can adopt AI in clinical trials in a compliant, audit-ready way.

How to adopt AI as a CRO

CRO operations infrastructure: fragmented legacy systems versus unified tech-enabled stack for clinical trials.

Becoming a Tech-Enabled CRO

Diagram contrasting two clinical trial operating models. On the left, "Today": the CRO owns the eClinical platform, data, and admin rights, while the biotech sponsor rents access. On the right, "Tomorrow — Bring Your Own CRO": the biotech sponsor owns the platform, data, and infrastructure, while the CRO logs in as a swappable execution partner.

Bring Your Own CRO

The First AI Warning Letter: FDA Doubles Down on Mandatory Human Oversight - Carelane

The First AI Warning Letter: FDA Doubles Down on Mandatory Human Oversight

The Velocity Paradox: Why "Safe" is the New Risky in Clinical Development — Carelane

The Velocity Paradox: Why "Safe" is the New Risky in Clinical Development

Doctor analyzing data and graphs on a laptop at a desk.

August 15, 2025

Carelane sets new standards for clinical research with AI-driven, end-to-end platform

Snow-covered mountain peak under a clear blue sky.

Carelane Raises €800,000 in Pre-Seed Funding to Revolutionize Clinical Trial Software

Three doctors in white coats having a discussion in a modern building with a green world map on the wall.

ECMM has launched the Candida IV study, involving over 100 sites worldwide

Ready to try Carelane?

From protocol to a complete study build in minutes.
Experience the world's fastest infrastructure for modern clinical trials.

Start Your Registry

User interface of Carelane software showing site managemen.

User interface of Carelane software showing Chatbot.

Portrait Yannick Boerner – CEO & co-Founder

Yannick Boerner

CEO, CTO & co-Founder